NCT01867593View on ClinicalTrials.gov

MET-PET for Newly Diagnosed Glioblastoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Glioblastoma
Interventions
DEVICE

C-11 methionine PET

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01867593 - MET-PET for Newly Diagnosed Glioblastoma | Biotech Hunter | Biotech Hunter